Search results
Results From The WOW.Com Content Network
U-47700, also known as U4, pink heroin, pinky, and pink, is an opioid analgesic drug developed by a team at Upjohn in the 1970s [1] which has around 7.5 times the potency of morphine in animal models. [2] [3] [4] Physical Sample of U-47700 [5]
In 1890, G. T. Fulford & Company purchased the rights to produce Dr. Williams' Pink Pills for Pale People for $53.01 after encountering a pill prescribed by a local physician, William Jackson, [3] and began marketing it through Dr. Williams Medicine Company. Reverend Enoch Hill of M.E. Church of Grand Junction in Iowa, endorsed the product in ...
The pill was subsequently approved for use in June 1999, when Japan became the last UN member country to do so. [233] However, the pill has not become popular in Japan. [234] According to estimates, only 1.3 percent of 28 million Japanese females of childbearing age use the pill, compared with 15.6 percent in the United States.
A panel of U.S. Food and Drug Administration experts decided Friday that Boehringer Ingelheim's so-called "female viagra" drug, flibanserin, doesn't provide enough benefit to outweigh the risks.
Levonorgestrel is a hormonal medication which is used in a number of birth control methods. [7] [11] It is combined with an estrogen to make combination birth control pills. [12]
Some of the more common terms are modified versions of the trade name "Xanax", such as Xannies (or Xanies) and the phonetic equivalent of Zannies; [131] [132] references to their drug classes, such as benzos or downers; or remark upon their shape or color (most commonly a straight, perforated tablet or an oval-shaped pill): bars, ladders ...
Meprobamate—marketed as Miltown by Wallace Laboratories and Equanil by Wyeth, among others—is a carbamate derivative used as an anxiolytic drug. It was the best-selling minor tranquilizer for a time, but has largely been replaced by the benzodiazepines due to their wider therapeutic index (lower risk of toxicity at therapeutically prescribed doses) and lower incidence of serious side effects.
PNU-99,194(A) (or U-99,194(A)) is a drug which acts as a moderately selective D 3 receptor antagonist with ~15-30-fold preference for D 3 over the D 2 subtype. [1] [2] [3] Though it has substantially greater preference for D 3 over D 2, the latter receptor does still play some role in its effects, as evidenced by the fact that PNU-99,194 weakly stimulates both prolactin secretion and striatal ...